SI
GH icon

Stirlingshire Investments’s Guardant Health GH Stock Holding History

Stirlingshire Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
+1,473
New +$160K 0.16% 199

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Stirlingshire Investments's GH Position: Q2 2026 in Review

Stirlingshire Investments opened a new position in Guardant Health (GH) in Q2 2026: 1,473 shares worth $221K. The stake represents 0.16% of the portfolio and ranks #199 among its holdings.

597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Stirlingshire Investments held 1,473 shares of Guardant Health worth $221K as of Q2 2026.
  • Guardant Health was a new Stirlingshire Investments position in Q2 2026.
  • Guardant Health made up 0.16% of Stirlingshire Investments's portfolio in Q2 2026, its #199 holding.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Stirlingshire Investments's 13F filing for Q2 2026, filed 31 Jul 2026.